Corporate News
Notice of Results and Investor Presentation
15 November 2024
Cambridge Nutritional Sciences plc (AIM:CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, confirms it will issue its Half Year results for the six months ended 30 September 2023 on Thursday 21 November 2024.
Investor presentation
There will be a live presentation relating to the Half Year Results via the Investor Meet Company platform on Thursday 21 November 2024 at 16:00 GMT.
The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 20 Nov 2024, 09:00 GMT, or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Cambridge Nutritional Sciences plc via:
https://www.investormeetcompany.com/cambridge-nutritional-sciences-plc/register-investor
Investors who already follow Cambridge Nutritional Sciences plc on the Investor Meet Company platform will automatically be invited.
Contacts:
Cambridge Nutritional Sciences plc | ||
Carolyn Rand, Executive Chair | ||
James Cooper, Interim Chief Executive | ||
Cavendish Capital Markets Limited | Tel: 020 7220 0500 | |
Geoff Nash / Edward Whiley / (Corporate Finance) | ||
Nigel Birks / Harriet Ward (ECM) | ||
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
